Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTHScott Kaatz, Sam Schulman, Ahmad Danesh et al.|Journal of Thrombosis and Haemostasis|2015Cited by 1.4k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationJohn W. Eikelboom, Salim Yusuf, Lars Wallentin et al.|Circulation|2011Cited by 1.1k
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trialSusan R. Kahn, Jeffrey S. Ginsberg, Christina Holcroft et al.|The Lancet|2013Cited by 522
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz, Jack Ansell, Peter A. Kouides et al.|American Journal of Hematology|2012Cited by 366
<scp>d</scp>-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant TherapyClive Kearon, Frederick A. Spencer, Denis O’Keeffe et al.|Annals of Internal Medicine|2015Cited by 146